Business
Press Release May 13 2025
Aurobindo Pharma Limited has informed the Exchange regarding a press release dated May 13, 2025, titled "CuraTeQ Biologics receives approval for biosimilar Zefylti from UK s MHRA".
About this update from Aurobindo Pharma Ltd
[{"type":"text","content":" Aurobindo Pharma Limited has informed the Exchange regarding a press release dated May 13, 2025, titled \"CuraTeQ Biologics receives approval for biosimilar Zefylti from UK s MHRA\". View Attachment","length":350,"tagName":"div"}]